National Heart, Lung, and Blood Institute
|This article needs additional citations for verification. (October 2014)|
The National Heart, Lung, and Blood Institute (NHLBI) is the third largest Institute of the National Institutes of Health, located in Bethesda, Maryland, USA. It is tasked with allocating about $3.0 billion in tax revenue per year (fiscal year 2015 estimate) to advancing the understanding of the following issues: development and progression of disease, diagnosis of disease, treatment of disease, disease prevention, reduction of health care disparities within the American population, and advancing the effectiveness of the U.S. medical system. NHLBI's Director is Gary H. Gibbons, M.D.
NHLBI is best described by its mission statement, which reads as follows:
The National Heart, Lung, and Blood Institute (NHLBI) provides leadership for a national program in diseases of the heart, blood vessels, lung, and blood; blood resources; and sleep disorders. Since October 1997, the NHLBI has also had administrative responsibility for the NIH Woman's Health Initiative.
The Institute plans, conducts, fosters, and supports an integrated and coordinated program of basic research, clinical investigations and trials, observational studies, and demonstration and education projects. Research is related to the causes, prevention, diagnosis, and treatment of heart, blood vessel, lung, and blood diseases, and sleep disorders. The NHLBI plans and directs research in development and evaluation of interventions and devices related to prevention, treatment, and rehabilitation of patients suffering from such diseases and disorders. It also supports research on clinical use of blood and all aspects of the management of blood resources. Research by scientific institutions and individuals is supported by research grants and contractss through the NHLBI Extramural Program, while the NHLBI Division of Intramural Research conducts state-of-the-art research on the NIH Besthesda campus in its own laboratories.
For health professionals and the public, the NHLBI conducts educational activities, including development and dissemination of materials in the above areas, with an emphasis on prevention.
The NHLBI supports research training and career development of new and established researchers in fundamental sciences and clinical disciplines to enable them to conduct basic and clinical research related to heart, blood vessel, lung, and blood diseases, sleep disorders, and blood resources through individual and institutional research training awards and career development awards.
The NHLBI coordinates relevant activities in the above areas, including the related causes of stroke, with other research institutes and federal health programs. Relationships are maintained with institutions and professional associations, and with international, national, state, and local officials as well as voluntary agencies and organizations working in the above areas.
The NHLBI Division of Intramural Research (DIR) in Bethesda conducts research and training in a wide variety of areas broadly related to the mission of the Institute, both clinical research and basic science research. There are 60 investigators, each of whom runs their own research program. They are supported by a group of core services that implement state-of-the-art techniques available to all NHLBI investigators. The NHLBI is home to Marshall Nirenberg, Nobel Laureate for his discovery of the genetic code. The DIR also has a large training component, with opportunities for undergraduate, graduate, and medical students as well as Postdoctoral training for Ph.D. and M.D. graduates.
Notes and references
- "NHLBI Mission Statement". National Heart Lung and Blood Institute. Retrieved June 20, 2011.
- NHLBI Homepage
- NHLBI Mission Statement
- John T. Watson Papers (1964-2003) - National Library of Medicine finding aid for a former administrator of the NHLBI's artificial heart program